top of page
Search

EIDD-2801 vs. EIDD-1931 (Molnupiravir): What’s the Difference and Which One Is Best for FIP Treatment?

When it comes to antiviral treatment for Feline Infectious Peritonitis (FIP), many cat owners and veterinarians come across two chemical names: EIDD-2801 and EIDD-1931. Although they are closely related, they are not the same compound, and understanding their differences is essential for choosing the right treatment for your cat.

97% success in FIP recovery Molnupiravir

Molnupiravir EIDD-1931 EIDD-2801 FIP Treatment: Understanding the Difference What Is EIDD-2801 (Molnupiravir)?

EIDD-2801, also known as Molnupiravir, is an oral prodrug. That means it is a precursor compound that is metabolized in the body to become the active antiviral agent. Once administered, EIDD-2801 converts into EIDD-1931, the compound that actually fights the virus.

Originally developed for human use against RNA viruses like COVID-19, EIDD-2801 showed high bioavailability and convenient oral administration, making it an attractive option in both human and veterinary medicine.

What Is EIDD-2801 (Molnupiravir)?

EIDD-1931, also known as N4-hydroxycytidine, is the active metabolite of EIDD-2801. It is the molecule responsible for interfering with viral RNA replication. In the context of FIP, this compound has shown a 97% success rate when used in treatment regimens.

At MolnuFIP™, the product sold is directly based on EIDD-1931, delivered in soft gel capsules for easy oral use. This removes the need for metabolic conversion, allowing the body to absorb and utilize the antiviral compound more efficiently.

Key Differences Between EIDD-2801 and EIDD-1931

Feature

EIDD-2801

EIDD-1931

Chemical Form

Prodrug

Active compound

Requires Conversion

Yes (to EIDD-1931)

No

Bioavailability

High

Higher (when directly administered)

Speed of Action

Slower onset

Faster action

Use in FIP

Less common

Widely used with high success rate

Why EIDD-1931 Is Preferred for FIP Treatment

  • Direct action: Since it’s already in active form, it begins working immediately after absorption.

  • Simplified dosing: No need to worry about metabolic efficiency or variability in conversion rates.

  • Higher purity: Products like those from MolnuFIP™ are GMP-certified and contain 99.9% pure EIDD-1931.

  • Proven success: Clinical studies and thousands of real-life cases support its effectiveness in treating both wet and dry forms of FIP. Molnupiravir EIDD-1931 EIDD-2801 FIP Treatment Reach us now Whatsappp:‭+971 55 294 4801‬

 
 
 

Kommentare

bottom of page